SELECT MEDICAL HOLDINGS CORP is an SEC registrant, filing under CIK 0001320414, classified as hospitals. It is grouped with Health Care companies on this site.
Footnote F2 (shares): Includes unvested shares of Company common stock subject to forfeiture conditions (the "Company Restricted Shares"). Pursuant the Merger Agreement, each Company Restricted Share held by the Reporting Person that was outstanding immediately prior to the effective time vested in… Full note on SEC EDGAR
Footnote F2 (shares): Includes unvested shares of Company common stock subject to forfeiture conditions (the "Company Restricted Shares"). Pursuant the Merger Agreement, each Company Restricted Share held by the Reporting Person that was outstanding immediately prior to the effective time vested in… Full note on SEC EDGAR
Footnote F2 (shares): Includes unvested shares of Company common stock subject to forfeiture conditions (the "Company Restricted Shares"). Pursuant the Merger Agreement, each Company Restricted Share held by the Reporting Person that was outstanding immediately prior to the effective time vested in… Full note on SEC EDGAR
Footnote F2 (shares): Includes unvested shares of Company common stock subject to forfeiture conditions (the "Company Restricted Shares"). Pursuant the Merger Agreement, each Company Restricted Share held by the Reporting Person that was outstanding immediately prior to the effective time vested in… Full note on SEC EDGAR
Footnote F2 (shares): Includes unvested shares of Company common stock subject to forfeiture conditions (the "Company Restricted Shares"). Pursuant the Merger Agreement, each Company Restricted Share held by the Reporting Person that was outstanding immediately prior to the effective time vested in… Full note on SEC EDGAR
Footnote F2 (shares): Includes unvested shares of Company common stock subject to forfeiture conditions (the "Company Restricted Shares"). Pursuant the Merger Agreement, each Company Restricted Share held by the Reporting Person that was outstanding immediately prior to the effective time vested in… Full note on SEC EDGAR
Footnote F2 (shares): Includes unvested shares of Company common stock subject to forfeiture conditions (the "Company Restricted Shares"). Pursuant the Merger Agreement, each Company Restricted Share held by the Reporting Person that was outstanding immediately prior to the effective time vested in… Full note on SEC EDGAR
Footnote F2 (shares): Immediately prior to the effective time of the merger, the Reporting Person contributed 78,043 common shares and 116,667 restricted shares to Parent in exchange for an equivalent amount of shares of common stock ("Parent Common Shares") and restricted shares, respectively, of… Full note on SEC EDGAR
Footnote F2 (shares): Immediately prior to the effective time of the merger, the Reporting Person contributed 31,751 common shares and 103,333 restricted shares to Parent in exchange for an equivalent amount of shares of common stock ("Parent Common Shares") and restricted shares, respectively, of… Full note on SEC EDGAR
Footnote F2 (shares): Immediately prior to the effective time of the merger, the Reporting Person contributed 100,000 restricted shares to Parent in exchange for an equivalent amount of restricted shares of Parent, which restricted shares were then exchanged for an equivalent amount of interests in… Full note on SEC EDGAR
Footnote F3 (shares): At the effective time of the merger, each of the Reporting Person's shares of common stock reported in this row of this Form 4 issued and outstanding immediately prior to the effective time of the merger was converted into the right to receive $16.50 per share in cash without… Full note on SEC EDGAR
Footnote F2 (shares): Immediately prior to the effective time of the merger, the Reporting Person contributed 40,000 restricted shares to Parent in exchange for an equivalent amount of shares restricted shares of Parent, which restricted shares were then exchanged for an equivalent amount of… Full note on SEC EDGAR
Footnote F3 (shares): At the effective time of the merger, each of the Reporting Person's shares of common stock reported in this row of this Form 4 issued and outstanding immediately prior to the effective time of the merger was converted into the right to receive $16.50 per share in cash without… Full note on SEC EDGAR
Footnote F2 (shares): Immediately prior to the effective time of the merger, the Reporting Person contributed 79,723 common shares and 158,334 restricted shares to Parent in exchange for an equivalent amount of shares of common stock ("Parent Common Shares") and restricted shares, respectively, of… Full note on SEC EDGAR
Footnote F2 (shares): Immediately prior to the effective time of the merger, the Reporting Person contributed 203,037 common shares and 158,333 restricted shares to Parent in exchange for an equivalent amount of shares of common stock ("Parent Common Shares") and restricted shares, respectively, of… Full note on SEC EDGAR
Footnote F2 (shares): Immediately prior to the effective time of the merger, the Reporting Person contributed 175,042 common shares and 216,667 restricted shares to Parent in exchange for an equivalent amount of shares of common stock ("Parent Common Shares") and restricted shares, respectively, of… Full note on SEC EDGAR
Footnote F2 (shares): Immediately prior to the effective time of the merger, the Reporting Person contributed 519,745 common shares and 216,667 restricted shares to Parent in exchange for an equivalent amount of shares of common stock ("Parent Common Shares") and restricted shares, respectively, of… Full note on SEC EDGAR
Footnote F2 (shares): Immediately prior to the effective time of the merger, the reporting person contributed 1,138,754 common shares and 244,667 restricted shares to Parent in exchange for an equivalent amount of shares of common stock ("Parent Common Shares") and restricted shares, respectively, of… Full note on SEC EDGAR
Footnote F3 (shares): Immediately prior to the effective time of the merger, the Reporting Person contributed 2,634 common shares to Parent in exchange for an equivalent amount of shares of Parent Common Shares, which Parent Common Shares were then exchanged for an equivalent amount of interests in… Full note on SEC EDGAR
Footnote F2 (shares): Immediately prior to the effective time of the merger, the Reporting Person contributed 6,674,010 common shares and 407,778 restricted shares to Parent in exchange for an equivalent amount of shares of common stock ("Parent Common Shares") and restricted shares, respectively, of… Full note on SEC EDGAR
Footnote F3 (shares): Immediately prior to the effective time of the merger, The Robert A. Ortenzio Descendants Trust contributed 1,000,000 common shares ("Rollover Shares") to Parent in exchange for an equivalent amount of Parent Common Shares, which Parent Common Shares were then exchanged for an… Full note on SEC EDGAR
Footnote F5 (shares): At the effective time of the merger, each of the shares of common stock reported in this row of this Form 4 issued and outstanding immediately prior to the effective time of the merger was converted into the right to receive $16.50 per share in cash without interest.
Footnote F6 (shares): Immediately prior to the effective time of the merger, The Robert A. Ortenzio 2014 Trust for Bryan A. Ortenzio contributed 280,415 common shares to Parent in exchange for an equivalent amount of Parent Common Shares, which Parent Common Shares were then exchanged for an… Full note on SEC EDGAR
Footnote F7 (shares): Immediately prior to the effective time of the merger, The Robert A. Ortenzio 2014 Trust for Kevin M. Ortenzio contributed 280,415 common shares to Parent in exchange for an equivalent amount of Parent Common Shares, which Parent Common Shares were then exchanged for an… Full note on SEC EDGAR
Footnote F8 (shares): Immediately prior to the effective time of the merger, The Robert A. Ortenzio 2014 Trust for Madeline G. Ortenzio contributed 280,415 common shares to Parent in exchange for an equivalent amount of Parent Common Shares, which Parent Common Shares were then exchanged for an… Full note on SEC EDGAR
Footnote F2 (shares): Immediately prior to the effective time of the merger, the Reporting Person contributed 610,035 common shares (including 14,035 restricted shares which vested immediately prior to the effective time of the merger) to Parent in exchange for an equivalent amount of shares of… Full note on SEC EDGAR
Footnote F2 (shares): Immediately prior to the effective time of the merger, the Reporting Person contributed 16,334 restricted shares ("Rollover Shares") to Parent in exchange for an equivalent amount of shares of common stock ("Parent Common Shares") and restricted shares, respectively, of Parent… Full note on SEC EDGAR
Footnote F3 (shares): At the effective time of the merger, each of the Reporting Person's shares of common stock reported in this row of this Form 4 issued and outstanding immediately prior to the effective time of the merger was converted into the right to receive $16.50 per share in cash without… Full note on SEC EDGAR
Footnote F4 (shares): Includes unvested shares of Company common stock subject to forfeiture conditions (the "Company Restricted Shares"). Pursuant the Merger Agreement, each Company Restricted Share (other than Rollover Shares) held by the Reporting Person that was outstanding immediately prior to… Full note on SEC EDGAR
SELECT MEDICAL HOLDINGS CORP (SEM) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-07-01. The full record for SEM runs to 71 Form 4 filings, the earliest from 2024-10-02. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying SEM stock?
No insider purchases of SEM were filed in the last 90 days.
How many insiders are selling SEM stock?
No insider sales of SEM were filed in the last 90 days. 4 sales are on record for this company.
Where can I see SEM SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects SEM Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
William H. FristDerivative$5.05M
Marilyn B. Tavenner
Parvinderjit S. Khanuja
David S. Chernow - Officer
Martin F. Jackson - Officer
